Vyriad, a gene therapy company based in Rochester, has raised $85 million to support its new VV-169 cancer treatment which ...

95% of clinical trials fail because animal testing is no substitute for human biology - Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap behind ...

Understand why testing must evolve beyond deterministic checks to assess fairness, accountability, resilience and ...

HITL is essentially a feedback loop where humans oversee the work to refine the model. The goal is transparency and ...